RBGLY Stock - Reckitt Benckiser Group plc
Unlock GoAI Insights for RBGLY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $14.17B | $14.61B | $14.45B | $13.23B | $13.99B |
| Gross Profit | $8.60B | $8.76B | $8.36B | $7.69B | $8.44B |
| Gross Margin | 60.7% | 60.0% | 57.8% | 58.1% | 60.3% |
| Operating Income | $2.42B | $2.53B | $3.25B | $-804,000,000 | $2.16B |
| Net Income | $1.43B | $1.64B | $2.33B | $-32,000,000 | $1.19B |
| Net Margin | 10.1% | 11.2% | 16.1% | -0.2% | 8.5% |
| EPS | $0.41 | $0.46 | $0.65 | $-0.02 | $0.33 |
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 15th 2025 | Morgan Stanley | Downgrade | Equal Weight | - |
| February 4th 2025 | Barclays | Downgrade | Equal Weight | - |
| December 11th 2024 | HSBC Securities | Upgrade | Buy | - |
| August 29th 2024 | JP Morgan | Downgrade | Neutral | - |
| January 9th 2024 | Exane BNP Paribas | Upgrade | Neutral | - |
| December 11th 2023 | Jefferies | Downgrade | Underperform | - |
| December 11th 2023 | Bernstein | Upgrade | Outperform | - |
| November 14th 2023 | Morgan Stanley | Downgrade | Equal Weight | - |
| October 27th 2023 | Berenberg | Downgrade | Hold | - |
| October 26th 2023 | HSBC Securities | Downgrade | Hold | - |
| September 12th 2023 | Exane BNP Paribas | Downgrade | Underperform | - |
| March 6th 2023 | Deutsche Bank | Downgrade | Hold | - |
| January 9th 2023 | Societe Generale | Upgrade | Buy | - |
| October 31st 2022 | Jefferies | Upgrade | Hold | - |
| May 18th 2022 | RBC Capital Mkts | Upgrade | Outperform | - |
Earnings History & Surprises
RBGLYEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 4, 2026 | — | — | — | — |
Q2 2025 | Jun 30, 2025 | $0.44 | $0.38 | -13.9% | ✗ MISS |
Q4 2024 | Dec 31, 2024 | $0.39 | $0.10 | -74.1% | ✗ MISS |
Q2 2024 | Jun 29, 2024 | $0.39 | $0.41 | +3.3% | ✓ BEAT |
Q4 2023 | Dec 30, 2023 | $0.37 | $0.14 | -61.6% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | $0.43 | $0.43 | +0.7% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | $0.41 | $0.34 | -17.4% | ✗ MISS |
Q3 2022 | Jul 27, 2022 | $0.36 | $0.46 | +26.8% | ✓ BEAT |
Q2 2022 | Apr 29, 2022 | $0.40 | $0.64 | +59.5% | ✓ BEAT |
Q4 2021 | Oct 26, 2021 | $0.39 | $-0.67 | -269.5% | ✗ MISS |
Q4 2020 | Dec 31, 2020 | $0.44 | $0.04 | -90.4% | ✗ MISS |
Q4 2020 | Oct 20, 2020 | $0.43 | $0.38 | -13.4% | ✗ MISS |
Q2 2020 | Apr 30, 2020 | $0.48 | $-1.37 | -382.8% | ✗ MISS |
Q3 2019 | Jul 30, 2019 | — | $0.04 | — | — |
Q2 2019 | May 2, 2019 | — | $0.49 | — | — |
Q3 2018 | Jul 27, 2018 | — | $0.32 | — | — |
Q1 2018 | Feb 19, 2018 | — | $0.98 | — | — |
Q4 2017 | Oct 18, 2017 | — | $0.28 | — | — |
Q2 2017 | Apr 21, 2017 | — | $0.43 | — | — |
Q4 2016 | Oct 19, 2016 | — | $0.18 | — | — |
Latest News
Frequently Asked Questions about RBGLY
What is RBGLY's current stock price?
What is the analyst price target for RBGLY?
What sector is Reckitt Benckiser Group plc in?
What is RBGLY's market cap?
Does RBGLY pay dividends?
Similar Stocks
Consumer Defensive SectorExplore stocks similar to RBGLY for comparison